Fintel reports that on March 13, 2025, Citigroup initiated coverage of Apogee Therapeutics (NasdaqGM:APGE) with a Buy ...
Hosted on MSN11mon
Apogee (APOG) to Report Q4 Earnings: What's in the Cards?Our proven model does not conclusively predict an earnings beat for Apogee this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback